Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00443859 · ClinicalTrials.gov registry record
N-Terminal Pro-brain Natriuretic Peptide Hormone and Persistent Pulmonary Hypertension
A clinical trial, sponsored by Christiana Care Health Services.
- Terminated
- Registry status
- 10
- Enrollment target
NCT00443859: Clinical Trial study, sponsored by Christiana Care Health Services.
NCT00443859 is a clinical trial that was terminated before completion, run by Christiana Care Health Services. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00443859 was terminated before completion, sponsored by Christiana Care Health Services.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
Babies who are suspected of having persistent pulmonary hypertension (PPHN) will be included in this study. PPHN is a condition in which the blood is restricted from flowing to the lungs in a normal way making it hard for babies to breath and placing strain on the heart. This study will observe whether certain hormones that measure stress (N-terminal pro-brain natriuretic peptide) can help determine how well a baby will do when they have PPHN.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-09 |
Why NCT00443859 stopped before completion
NCT00443859 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00443859 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00443859 about?
NCT00443859 is a clinical study titled "N-Terminal Pro-brain Natriuretic Peptide Hormone and Persistent Pulmonary Hypertension". Babies who are suspected of having persistent pulmonary hypertension (PPHN) will be included in this study. PPHN is a condition in which the blood is restricted from flowing to the lungs in a normal way making it hard for babies to breath and placing strain on the heart. This study will observe whet...
What is the current status of trial NCT00443859?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2007-02. Estimated completion is 2008-09.
Who is sponsoring clinical trial NCT00443859?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia